Magnetic Nanoparticle-Based Hyperthermia for Cancer Treatment: Factors Affecting Heat Generation Efficiency

2017 ◽  
pp. 393-424 ◽  
Author(s):  
Yasir Javed ◽  
Khuram Ali ◽  
Yasir Jamil
2019 ◽  
Vol 123 (36) ◽  
pp. 22499-22510 ◽  
Author(s):  
Constantinos Moularas ◽  
Yiannis Georgiou ◽  
Katarzyna Adamska ◽  
Yiannis Deligiannakis

Energies ◽  
2019 ◽  
Vol 12 (3) ◽  
pp. 355 ◽  
Author(s):  
Tao Yi ◽  
Ling Tong ◽  
Mohan Qiu ◽  
Jinpeng Liu

With the increasing consumption of fossil energy and changes in the ecological environment, meeting the energy demands required for industrial and economic development with clean and efficient power generation is a major challenge of our society. Solar energy is considered to be one of the most renewable and sustainable energy sources, and photovoltaic power generation has become an important research topic. This study combines data envelopment analysis (DEA) with Tobit regression analysis to assess the efficiency of photovoltaic power generation in China and analyze factors affecting efficiency to improve the efficiency of photovoltaic power generation. The results show that there are obvious regional differences in photovoltaic power generation efficiency in China. The phenomenon of focusing on economic development at the expense of the use of solar power generation still exists. The establishment of photovoltaic demonstration projects, the implementation of differential electricity price policies, and the promotion of photovoltaic precision poverty alleviation can alleviate economic pressure and effectively improve the efficiency of photovoltaic power generation.


Nanoscale ◽  
2015 ◽  
Vol 7 (29) ◽  
pp. 12728-12736 ◽  
Author(s):  
Christopher A. Quinto ◽  
Priya Mohindra ◽  
Sheng Tong ◽  
Gang Bao

Superparamagnetic iron oxide nanoparticles optimized with a phospholipid-PEG coating achieve high Doxorubicin loading and heat generation for an enhanced multimodal cancer treatment.


Author(s):  
Saleh S. Hayek ◽  
Ching-Jen Chen ◽  
Yousef S. Haik ◽  
Mark H. Weatherspoon

Hyperthermia (HT) is a cancer treatment that utilizes a variety of heating methods to destroy cancerous tumors. A diversity of technical problems still exists regarding HT's different approaches, therapeutic potential, and evidence of effectiveness. The foremost problem is in generating and controlling heat in tumors to target cancer sites. The window of temperature for HT is between 42°C and 45°C, with the literature suggesting 43°C to be the ideal temperature for inducing apoptosis (programmed cell death). Normal cells undergo necrosis at higher temperatures than that of the specified range. To address control problems, various methods have been utilized to localize HT heating and limit its temperatures through various applicators, materials, and procedures. One method has been to implant various materials into the human body to heat tumors, a process known as Magnetic Hyperthermia (MH) as it uses magnetic nanoparticles (NP). This method is particularly useful for sending thermal energy to deep seated tumors by using ferro/ferri magnetic NP that absorb non-ionizing electromagnetic (EM) fields delivered into the human body externally. These NP have been shown to heat surrounding tissue until they reach a Curie temperature (Tc) at which generated heat is minimized (many thermodynamic properties change at Tc, such as dielectric, elastic, optical and thermal properties. Fabricated NP, due to spontaneous polarization, can heat via hysteresis losses under applied EM fields making them candidates for testing in (EM) HT systems. Various ferro- and ferromagnetic materials have been studied extensively by this group (e.g.: Ni-Cu, Ni-Co, Ni-Cr, Er, Ce, Gd, and their alloys, etc.) as candidates for HT due to their production of heat through hysteresis or magnetic spin mechanisms. With the use of these nanoparticle systems, the focus of this paper is to produce analysis of heat generation through electromagnetic energy conversion for magnetic hyperthermia cancer treatment and to investigate the heat transfer and heat generation of magnetic NP due to temperature rise upon application of externally applied AC magnetic field. Both, polarization switching and inhomogenities affect polarization orientation within a crystal. Domain switching occurs in two steps: first, the domain nucleates at critical level of applied EM field; second, the interface between the two domains propagates. Particles moving across the interface transform from one domain type to another, which leads to a release of energy in the form of heat. This, in turn, leads to a temperature rise at the interface.


Author(s):  
David A. Chambers ◽  
Wynne E. Norton ◽  
Cynthia A. Vinson

THE ROOTS of implementation science (IS) in cancer in some sense date back to the earliest days of uncovering cancer’s etiology, diagnosis, prevention, and treatment, although it was not called that. Indeed, unlocking the mysteries of cancer and determining effective ways to intervene began not in the lab but, rather, the clinic. As Mukherjee recounted in the seminal work, The Emperor of All Maladies, 1 cancer had been the subject of clinical examination for centuries, and the drive to optimize care began in those early days. As opposed to the largely separate worlds of research discovery and care delivery that exist today, scientific research and cancer treatment coexisted. In addition, epidemiologic observations of risk factors affecting oncogenesis developed targets for what types of prevention programs needed to be implemented. Naturally, the challenges of what exactly to implement and how best to implement have been with us throughout time.


2002 ◽  
Vol 20 (2) ◽  
pp. 545-556 ◽  
Author(s):  
Kathyrn Roche ◽  
Nancy Paul ◽  
Bobbi Smuck ◽  
Marlo Whitehead ◽  
Benny Zee ◽  
...  

PURPOSE: Increasingly, cancer treatment centers need to be able to estimate specific costs and resources associated with clinical trials. Because the time requirements of trial coordination and data collection are not well known, the Clinical Research Associates (CRA) Committee of the National Cancer Institute of Canada Clinical Trials Group carried out a multicenter study to measure trials’ task times and evaluate the effects of certain factors. METHODS: A data collection instrument was designed and validated before its implementation in the study. Eighty-three CRAs from 24 cancer treatment institutions across Canada collected timing observations of 41 tasks (156 subtasks). Information from all stages of trials activity (protocol management, eligibility and entry, treatment, and follow-up and final stage) was obtained, from initial negotiations to follow-up after study closure. RESULTS: After controlling for stage, phase and sponsor were found to be significant independent factors. Analysis within the stages showed similar patterns. New drug inclusion as a factor was confounded with phase. Industry-sponsored studies had significantly higher overall mean times than did local and cooperative group studies. Early-phase studies required more time than did phase III trials. External sponsorship of any kind increased CRA time more than that necessary for locally coordinated studies, except during the protocol management stage. The burden of a phase I study increased to greater than average once underway and accruing patients. CONCLUSION: Our data demonstrated that sponsor and study phase are important factors to be taken into consideration when estimating clinical trial costs and resource use.


RSC Advances ◽  
2017 ◽  
Vol 7 (73) ◽  
pp. 46271-46285 ◽  
Author(s):  
Mariappan Rajan ◽  
Poorani Krishnan ◽  
Periyakaruppan Pradeepkumar ◽  
Mayandi Jeyanthinath ◽  
Murugaraj Jeyaraj ◽  
...  

We portray a novel way to synthesis of iron oxide magnetic nanoparticle incorporated β-cyclodextrin (β-CD) nanocarrier stabilized by ethylenediamine tetra acetic acid (EDTA) obtaining remarkable biocompatibility and biodegradability.


Sign in / Sign up

Export Citation Format

Share Document